ARTICLE
21 May 2026

The Week In Weed: May 15, 2026

SS
Seyfarth Shaw LLP

Contributor

With approximately 1,000 lawyers across 17 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
From Idaho's signature-gathering efforts to federal rescheduling clarifications, this week's cannabis update explores the complex landscape of marijuana legalization across state and federal jurisdictions.
United States Cannabis & Hemp
Susan Ryan’s articles from Seyfarth Shaw LLP are most popular:
  • with readers working within the Insurance industries
Seyfarth Shaw LLP are most popular:
  • within Compliance topic(s)

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we have signature-gathering news from Idaho. The Congressional Research Service issued a new report on rescheduling. The White House drug czar has a good reminder about marijuana’s legal status. And finally, the DC cannabis scene is livelier than you might expect.

IDAHO

As those of us who have followed the cannabis saga over the past few years know all too well, the road to legalization is littered with obstacles and setbacks. One of those involves gathering signatures to put a legalization measure on the state ballot. Pro-cannabis group National Medicine Alliance of Idaho has just submitted twice the number of signatures needed to qualify for November’s election in the Gem State. Even though some signatures will be disqualified (true of any ballot initiative, not just ones involving cannabis), you’d think they’d be in the clear. But it’s not over ’til it’s over, so stay tuned.

CRS REPORT

Federal rescheduling has led to an avalanche of articles on how this will change the industry, what’s now legal, and when business expenses can be deducted on tax returns. If you’re searching for a calm, well-researched, hype-free examination of the situation, have a look at the recent report put out by the Congressional Research Service (CRS).

IMPORTANT REMINDER

The White House drug czar, Sara Carter Bailey, would like to make it clear that cannabis is still illegal.

Executive-level Schedule III allows for doctors and research and for medicine, for medicinal purposes.

Meaning, for those of you in the back, that adult-use cannabis is still prohibited under federal law.

AND FINALLY

You can be forgiven for thinking that the DC cannabis industry might be more cloak and dagger than wild and crazy. Medical marijuana is legal, but adult-use is not, even though voters backed it years ago, thanks to Congress saying NO. (If you’d like to know a whole lot more about the DC legislative process, check out one of very early blog posts on the topic. And yes, that John Oliver link still works, and is well worth watching.) In fact, the DC cannabis scene is pretty diverse, including both bars and wellness. Of course, this is for medical purposes only, but you can self-certify to that – no doctor’s note needed.

Be well everyone – we’ll see you next week.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More